Contribution of Moxifloxacin or Levofloxacin in Second-Line Regimens with or without Continuation of Pyrazinamide in Murine Tuberculosis

Systematic Analysis of Pyrazinamide-Resistant Spontaneous Mutants and Clinical Isolates of Mycobacterium tuberculosis

(2012) Karolien Stoffels et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pyrazinamide May Improve Fluoroquinolone-Based Treatment of Multidrug-Resistant Tuberculosis

(2012) Kwok-Chiu Chang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium

(2012) S. E. Dorman et al.   JOURNAL OF INFECTIOUS DISEASES

High-Sensitivity MALDI-MRM-MS Imaging of Moxifloxacin Distribution in Tuberculosis-Infected Rabbit Lungs and Granulomatous Lesions

(2011) Brendan Prideaux et al.   ANALYTICAL CHEMISTRY

Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis

(2011) Rokeya Tasneen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses

(2011) Kwok Chiu Chang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis

(2010) Robert S. Wallis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment Outcomes among Patients with Extensively Drug‐Resistant Tuberculosis: Systematic Review and Meta‐Analysis

(2010) Karen R. Jacobson et al.   CLINICAL INFECTIOUS DISEASES

Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig

(2010) Z. Ahmad et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study

(2010) Keertan Dheda et al.   LANCET

Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis

(2009) Susan E. Dorman et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis

(2009) D. Almeida et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fourth-generation fluoroquinolones in tuberculosis

(2009) Hans L Rieder   LANCET

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

(2009) Marcus B Conde et al.   LANCET

Using Animal Models to Develop New Treatments for Tuberculosis

(2008) Eric Nuermberger   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE